EP3256125
SKAMMTAÁÆTLUN FYRIR PONESIMOD, SÉRTÆKAN S1P1 VIÐTAKAÖRVA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.12.2015EP published:
26.1.2022EP application number:
15807916.0
EP translation filed:
10.3.2022Grant published:
15.4.2022EPO information:
European Patent Register
Max expiry date:
9.12.2035Expiry date:
9.12.2026Next due date:
31.12.2026
Title in English:
DOSING REGIMEN FOR PONESIMOD, A SELECTIVE S1P1 RECEPTOR AGONISTLanguage of the patent:
English
Timeline
Today
10.12.2015EP application
26.1.2022EP Publication
10.3.2022Translation submitted
15.4.2022Registration published
9.12.2026Expires
Owner
Name:
Laboratoires Juvise PharmaceuticalsAddress:
149, Boulevard Bataille de Stalingrad,, 69100, Villeurbanne, FR
Inventor
Name:
DINGEMANSE, JasperAddress:
4123 Allschwil, CH
Name:
HOCH, MatthiasAddress:
Cambridge Cambridgeshire CB22 7PT, GB
Name:
KRAUSE, AndreasAddress:
4123 Allschwil, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/EP2014/077469Date:
11.12.2014Country:
WO
Number:
PCT/EP2015/058202Date:
15.4.2015Country:
WO
Supplementary protection
SPC number:
SPC375
Classification
Categories:
A61K 31/426, A61P 37/06, A61P 17/06, A61P 3/10, A61P 35/00, A61P 35/04, A61P 11/06, A61P 19/02, A61P 13/12, A61P 11/02, A61P 27/02, A61P 17/00, A61P 25/00, A61P 1/00, A61P 1/04
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 9.11.2022
Expires: 9.12.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 15.11.2023
Expires: 9.12.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 27.12.2024
Expires: 9.12.2025
Payer: iPify
Number: 11
Paid: 11.12.2025
Expires: 9.12.2026
Payer: G.H. Sigurgeirsson ehf.